story of the week
20-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial
J. Clin. Oncol 2022 Jul 21;[EPub Ahead of Print], A Johansson, H Dar, LJ van 't Veer, NP Tobin, G Perez-Tenorio, A Nordenskjöld, U Johansson, J Hartman, L Skoog, C Yau, CC Benz, LJ Esserman, O Stål, B Nordenskjöld, T Fornander, LS LindströmFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.